FIGURE

Figure 2

ID
ZDB-FIG-211002-71
Publication
Lu et al., 2021 - Exacerbation of Liver Tumor Metastasis in twist1a+/xmrk+ Double Transgenic Zebrafish following Lipopolysaccharide or Dextran Sulphate Sodium Exposure
Other Figures
All Figure Page
Back to All Figure Page
Figure 2

Figure 2. Induction of tumor metastasis in twist1a+/xmrk+ transgenic zebrafish via treatment with Dox in high concentrations. Twist1a+, xmrk+, and twist1a+/xmrk+ transgenic zebrafish as well as wild-type control were treated with 60 μg/mL Dox and 1 μg/mL 4-OHT starting from 3 mpf. Samples were collected at 2 and 4 wpi. (A) Representative images of transgenic zebrafish at 4 wpi. The left column displays external appearance, the middle column shows internal abdominal organs with the livers outlined, and the right column depicts H&E staining of liver sections. Scale bar: 50 or 200 μm. Compared with the wild-type group, (B) the body lengths of transgenic zebrafish differed significantly at 2 wpi but not at 4 wpi, whereas (C) the body weights of transgenic zebrafish differed significantly at 2 and 4 wpi. (D) Kaplan–Meier survival curves of days post-induction plotted against percent survival to 4 wpi. (E) Immunofluorescence analysis of liver tumor metastasis in twist1a+/xmrk+ transgenic zebrafish at 4 wpi. (F) Histological examination confirmed that xmrk+ and twist1a+/xmrk+ transgenic zebrafish developed HCC or metastatic HCC at 2 and 4 wpi, whereas normal liver histology was observed in all twist1a+ and wild-type siblings. Differences among variables were assessed using Student’s t-tests or one-way ANOVA. Statistical significance: * p < 0.05, ** p < 0.01, *** p < 0.001.

Expression Data

Expression Detail
Antibody Labeling
Phenotype Data
Fish:
Conditions:
Observed In:
Stage: Adult

Phenotype Detail
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Pharmaceuticals (Basel)